Atrial fibrillation (AF), a common tachyarrhythmia in clinical practice, is associated with increased oxidative stress. Structural remodelling in atrial myocytes, including myofibril degradation, is an important characteristic of AF. However, the mechanism underlying AF-induced cellular structural remodelling remains unclear. The aim of this study was to investigate the role of oxidative stress and related factors in tachycardia-induced atrial structural remodelling.
Introduction
Atrial fibrillation (AF), the most common sustained arrhythmia, is characterized by atrial electrical, contractile, and structural remodelling. 1, 2 Structural remodelling includes interstitial fibrosis, cellular remodelling in atrial myocytes, such as degradation/loss of myofibrils and glycogen deposition (also known as myolysis), changes in mitochondrial shape and size, and alterations in gap junction expression and distribution. 3, 4 These factors provide a substrate for AF and contribute to atrial hypocontractility, which in turn may cause systemic embolization in AF patients. 5 The mechanism underlying structural remodelling in atrial myocytes has not been clearly defined. Clinical and experimental studies have demonstrated that AF is associated with increased oxidative stress, which may † The first two authors contribute equally to this work.
promote interstitial fibrosis in the atrium. 6 -11 Atrial fibrosis results from the growth of non-myocytes, such as atrial fibroblasts, and the deposition of extracellular matrix. In this study, we evaluated in detail whether oxidative stress is also involved in structural remodelling of atrial myocytes. Transforming growth factor-b (TGF-b) is a well-characterized cytokine that participates in myocardial remodelling via mechanisms involving oxidative stress. 12, 13 Although much research has been devoted to understanding ventricular myocytes and cardiac fibroblasts, 12 -15 relatively little is known about the effects of TGF-b on atrial myocytes and its implication in AF.
A recent study indicates that rapid activation of atrial myocytes alters atrial fibroblast function and promotes extracellular matrix accumulation through a paracrine signalling. 16 Here, we suggest that rapidly activated atrial myocytes can produce substances, such as TGF-b and reactive oxygen products, to affect atrial myocytes themselves via autocrine and/or paracrine mechanisms. Rapid pacing of cultured atrial-derived myocytes mimics the phenotypic feature of tachycardia-induced remodelling in vivo. 16 -20 Therefore, we utilized the previously characterized HL-1 atrial-derived myocyte system to assess atrial myocyte remodelling and the potential signalling role of autocrine/paracrine TGF-b and oxidative stress systems. 21 The potential relevance of findings obtained from in vitro pacing was also verified in atrial tissue-samples from AF patients.
Methods

Materials
Most chemicals were purchased from Sigma (St Louis, MO, USA). Monoclonal neutralizing antibody against TGF-b1 was obtained from Abcam (ab64715, Cambridge, MA, USA).
Cell culture and tachypacing
HL-1 atrial myocytes were maintained in Claycomb medium and subjected to field stimulation as described previously. 16 -20 To induce tachycardia, HL-1 cells (≥1 × 10 6 cells) were cultured on four-well rectangular dishes (Nuclon, Netherlands) and placed into C-Dish 100TM-Culture Dishes (IonOptix, Milton, MA, USA). The spontaneous contraction rate was 0.5 -1 Hz as previously described. 16 -20 Cells were paced with 10-ms stimuli of 40-V intensity at selected frequencies. Capture efficiency .90% was confirmed by microscopic examination and by shortening of action potential duration as described previously (Supplementary material online, Figure S1 ). 17 In some experiments, HL-1 cells were pre-treated with the inhibitors [5 mmol/L N-acetylcysteine (NAC) or 100 mmol/L diphenylene iodonium (DPI)] for 2 h, or with neutralizing TGF-b1 antibody simultaneously. Atrial and ventricular fibroblasts obtained from adult Wistar rats were maintained in Dulbecco's modified Eagle's medium (DMEM) as described previously. 22 
Coculture of HL-1 cells and atrial fibroblasts
HL-1 cells at 50 -60% confluence were cocultured with atrial fibroblasts in Claycomb medium. These two types of cells could be distinguished easily by their morphology. Twenty-four hours later, the myocytes and fibroblasts were simultaneously subjected to field stimulation as described above.
Detection of intracellular oxidative stress
Intracellular oxidative stress from reactive oxygen species (ROS) was measured with fluorescent dye [2, 7-dichlorofluorescein diacetate (DCF-DA)] and detected by confocal microscope (Leica TCS SP2, Carl Zeiss, Jena, Germany) or flow cytometry. 23 HL-1 cells were pre-incubated with 5 mmol/L DCF for 30 min (378C) after pacing. DCF-DA was excited at 488 nm with an argon laser and emission at 525 nm was recorded. Two-dimensional images (512×512 pixels) were acquired.
Immunohisto-and cytochemical analyses
Immunohisto-and cytochemical analyses were performed by confocal microscopy using a-sarcomeric actin (a-actin), myosin heavy chain (MHC, Abcam), and phospho-Smad3 (p-Smad3, R&D Systems, Minneapolis, MN, USA) primary antibodies followed by FITC (green) or Cy3-conjugated secondary antibodies (red, Chemicon, Temecula, CA, USA). Nuclei were visualized by DAPI-staining. Myosin degradation was quantified as cytoplasmic myosin (MHC)-area divided by the nuclear area. The relative expression levels of MHC were normalized to the control level. Nuclear expression of p-Smad3 was calculated as p-Smad3-occupied area in the nucleus divided by the nucleus area. For each analysis, at least five random fields were chosen to observe .30 myocytes.
Immunoblotting
Immunoblotting was performed as described previously. 24 Equal amount of protein in SDS -polyacrylamide gel (PAGE) sample buffer was sonicated and subjected to electrophoresis on 12.5% SDS -PAGE. After transfer to nitrocellulose membranes (Stratagene, Netherlands), membranes were incubated with primary antibodies against Nox2/gp91 phox , Nox4
(Abcam), cTroponin I (Fitzgerald Industries), p-Smad3, total-Smad3 (R&D Systems), TGF-b1, and tubulin (Santa Cruz, Delaware Avenue, CA, USA). Signals were detected by an enhanced chemiluminescence substrate-detection method (Amersham, Netherlands) and quantified by densitometry. Signal-bands were in the linear immunoreactive range and expressed relative to tubulin.
TGF-b1 detection by ELISA in conditioned media
Conditioned media were obtained from non-paced and 24-h-paced (at 1, 2, and 4 Hz) HL-1 cells. The secretion of TGF-b1 by HL-1 cells was measured in conditioned media using a commercial TGF-b1 quantitative ELISA kit (900 -15, Assay Designs, Ann Arbor, MI, USA).
Calpain activity
Calpain enzymatic activity was determined by a calpain activity assay kit (K240-100, BioVision, Mountain View, CA) as described previously.
19,20
Small interfering (si) RNA
Chemically synthetic siRNAs for NADPH oxidases (Nox2/4), Smad3, and their control siRNAs were purchased from Dharmacon (Lafayette, CO, USA) and transferred into HL-1 cells using DharmaFECT 1 (Dharmacon) according to the manufacturer's instructions.
Patients
Right atrial appendages were obtained from six patients with chronic AF and four controls with sinus rhythm (SR) undergoing open-heart surgery (Supplementary material online, Table S1 ). After excision, atrial appendages were immediately frozen in liquid-N 2 and stored at 2858C. The investigation followed the principles of the Declaration of Helsinki. The Institutional Review Board approved the study and all patients gave written informed consent.
Statistical analysis
All values were expressed as the mean + SEM. Unpaired Student's t-test for two groups and one-way ANOVA with post hoc Tukey's tests for multiple comparisons were applied. A value of P , 0.05 was considered to be significant.
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Tachypacing induces TGF-b expression and secretion
HL-1 cells were subjected to pacing at various frequencies for 24 h. Tachypacing enhanced cellular TGF-b1 expression in a frequencydependent manner ( Figure 1A ). Secreted TGF-b1 was measured by ELISA in conditioned medium obtained from equal quantities of HL-1 cells paced at various frequencies for 24 h. Secreted TGF-b1 quantities were frequency-dependently increased in paced HL-1 cells ( Figure 1B) . Classically, TGF-b causes phosphorylation of cytoplasmic Smad3 and promotes its translocation into the nucleus, where it participates in transcriptional regulation. 25 Tachypacing led to a frequency-dependent increase in p-Smad3 expression ( Figure 1A ), which was reflected by enhanced nuclear p-Smad3 staining in tachypaced HL-1 cells ( Figure 1C ). These data suggest that tachycardia induces the expression and secretion of TGF-b and activates its downstream mediator (Smad3) in atrial myocytes.
Tachypacing induces oxidative stress
Tachypacing enhanced DCF-staining, indicating ROS generation, in time-and frequency-dependent manners ( Figure 2A and Supplementary material online, Figure S2 ). Previous studies demonstrate that NADPH oxidases (Nox) contribute greatly to the production of ROS in fibrillating atria. 6 -11 Western blot experiments confirmed that Nox2 and Nox4, the main isoforms of NADPH oxidases in myocytes, 26 were frequency-dependently up-regulated in rapidly activated HL-1 cells ( Figure 2B ). Furthermore, pre-treatment of activated HL-1 cells with NAC (a glutathione precursor and ROS scavenger) and DPI (a non-specific NADPH oxidase inhibitor) prevented tachypacinginduced ROS production, supporting the essential role of NADPH oxidase in tachycardia-stimulated oxidative stress ( Figure 2A and Supplementary material online, Figure S2 ). To further confirm the involvement of NADPH oxidase in tachycardia-induced oxidative stress, siRNAs specific for Nox 2 and 4 were used to inhibit NADPH oxidase expression. Both siRNAs suppressed the up-regulation of ROS production by tachypacing ( Figure 2C ). The specificity of siRNAs was documented by western blot in tachypaced cells ( Figure 2C ).
Tachypacing induces intracellular oxidative stress via TGF-b autocrine/ paracrine signalling
Because the effect of TGF-b is classically mediated by synthesis and release into the extracellular space, 27 the next experiments investigated whether tachycardia-induced oxidative stress can be mimicked by exogenous TGF-b1. Exogenously administered TGF-b1 augmented ROS production in both basal and rapidly paced HL-1 cells and p-Smad3 protein was evaluated by western blot as described in Methods. The expression of tubulin was used as an internal control. Bottom panel: the relative expression levels of TGF-b1, p-Smad3, and tubulin were quantified by densitometry and normalized to the control level, which was set at 1.0. Each value represents the mean + SE of four independent experiments. P , 0.05; *, †: the different symbols represent the significant difference among groups. (B) TGF-b1 released from tachypaced HL-1 cells was analysed by ELISA as described in Methods. TGF-b1 levels were normalized to cellular protein concentrations. Each value represents the mean + SE of three independent experiments. (C) Confocal immunohistochemical analysis reveals the nuclear translocation of p-Smad3 in HL-1 cells. Bottom: relative intensity of p-Smad3 staining measured in the nuclei of HL-1 cells is quantified. Data are means + SE (at least five random fields were chosen to observe .30 myocytes with scanning and averaging).
( Figure 3A) , suggesting a synergistic effect between tachypacing and TGF-b1. In contrast, the addition of neutralizing TGF-b1 antibody into cultured HL-1 cells attenuated tachypacing-induced ROS generation in a concentration-dependent manner, implicating an autocrine role for TGF-b in tachycardia-induced oxidative stress ( Figure 3B and Supplementary material online, Figure S2 ). We then assessed directly whether TGF-b1 produced by tachypaced HL-1 cells exerts effects on neighbouring cells via paracrine mechanisms. When HL-1 cells were incubated with conditioned media obtained from tachypaced HL-1 cells, ROS production increased ( Figure 3C ), although this effect required 48 h to develop. Conditioned media also enhanced ROS generation in isolated atrial fibroblasts ( Figure 3D) , with a stronger effect on atrial vs. ventricular fibroblasts ( Figure 3D) . Furthermore, these paracrine effects could be blocked by the addition of neutralizing TGF-b1 antibodies into the conditioned media ( Figure 3C and D) . Pacing in cocultured HL-1 cells and atrial fibroblasts increased ROS production in both cell types, which could also be attenuated by neutralizing TGF-b1 antibodies administration (Supplementary material online, Figure S3 ). These findings indicate that rapidly activated atrial myocytes release TGF-b, thereby altering their function as well as that of neighbouring myocytes and fibroblasts via autocrine and paracrine mechanisms.
Tachypacing induces cellular structural remodelling through oxidative stress and TGF-b signalling
Structural remodelling was studied in terms of myofibril degradation, including degradation of myosin (myolysis) and cTroponin I. As in previous studies, 19, 20 immunocytochemistry revealed that myolysis was concentrated around the nuclei of tachypaced HL-1 cells ( Figure 4A ). Tachypacing induced myolysis in a frequency-dependent manner ( Figure 4A ). Western blot demonstrated that the expression of cTroponin I decreased in tachypaced HL-1 cells compared with controls ( Figure 4B) . Furthermore, H 2 O 2 caused myosin degradation ( Figure 4A ), suggesting a potential role for oxidative stress in myolyis.
To assess directly the involvement of oxidative stress in tachycardia-induced structural remodelling, the effects of oxidative stress antagonists were studied. Pre-treatment with NAC or DPI protected tachypaced HL-1 cells from myolysis ( Figure 4C ) and decreased cTroponin I expression ( Figure 4D) . Furthermore, tachypacing-induced myofibril degradation could be inhibited by neutralizing TGF-b1 antibody ( Figure 4C and D) , indicating a role for TGF-b signalling.
To further evaluate the role of oxidative stress in tachycardiainduced structural remodelling, molecular knockdown of NADPH Figure 1A . The expression of Nox2, Nox4, and tubulin was evaluated by western blot. (C) Left panels: after transfection with indicated siRNAs and/or pacing for 24 h, the expression of Nox2, Nox4, and tubulin was evaluated by western blot. Right panels: intracellular ROS production was measured by fluorescent DCF dye using confocal microscope. Each value represents the mean + SE of four independent experiments. P , 0.05; *, †, #: the different symbols represent the significant difference among groups. con ¼ control.
Oxidative stress and TGF-b in AF remodelling oxidases (Nox2 and Nox4) was performed. Knockdown of Nox2 and Nox4 by respective siRNAs in tachypaced HL-1 cells significantly attenuated tachypacing-induced myosin degradation ( Figure 5A and B), whereas transfection with control siRNA had no such effect. These findings suggest that tachycardia-induced myofibril degradation requires intact NADPH oxidases.
Previous studies demonstrate a role for the Ca 2+ -dependent protease, calpain, in atrial structural remodelling. 19, 20 Therefore, we investigated whether oxidative stress and TGF-b modulate tachycardia-induced calpain activation. In agreement with previous studies, tachypacing frequency-dependently enhanced calpain activity in HL-1 cells ( Figure 5C ). Inhibition of oxidative stress (by NAC and DPI) and TGF-b1 neutralization significantly attenuated tachypacingstimulated calpain activity ( Figure 5C ). These data suggest that myofibril degradation as indicated by the activation of calpain is associated with oxidative stress and autocrine TGF-b signalling.
NADPH oxidases are required for tachypacing-induced Smad3 activation
Previous studies demonstrate a crosstalk between NADPH oxidases and Smad in mediating TGF-b-induced differentiation of cardiac and renal fibroblasts. 28, 29 The next experiments investigated whether NADPH oxidases are important for tachycardia-induced activation of Smad3. Pre-treatment of tachypaced HL-1 cells with ROS inhibitors (NAC and DPI) and neutralizing TGF-b1 antibody prevented tachypacing-induced phosphorylation of Smad3 ( Figure 4D ). Smad3-phosphorylation was also inhibited by Nox 2 and 4 siRNAs transfection ( Figure 5B ). We then utilized siSmad3 to clarify the role of Smad in mediating tachypacing-induced structural remodelling. Transfection with Smad3 siRNA suppressed the enhancement of p-Smad3 and Nox2/4 expression and ROS production in tachypaced HL-1 cells ( Figure 6A and B) . However, Smad3 siRNA transfection had no effect on tachypacing-induced cTroponin I expression and myosin degradation ( Figure 6B ). Taken together, these findings confirm an interrelation between NADPH oxidase and Smad3 in tachypacingstimulated ROS production. Other signals in addition to Smad3 may also play a role in mediating tachypacing-induced myofibril degradation.
TGF-b, oxidative stress, and myolysis increase in the atria of AF patients
We then evaluated whether changes similar to those that we observed in vitro are detectable in tissues from AF patients. Accordingly, we assessed the expression of TGF-b1, oxidative stress, and myosin degradation in the atria of patients with chronic AF or SR controls. Confocal immunohistochemistry revealed that TGF-b1, p-Smad3, and ROS were up-regulated in the atria of AF patients (Supplementary material online, Figure S4A and B). These changes were co-localized with a-actin expressing cells (a marker of myocyte). Furthermore, in comparison with control atria, the density of MHC decreased and its distribution became uneven in AF atria (Supplementary material online, Figure S4A and B), which is compatible with myosin degradation.
Discussion
Main findings
In this study, we demonstrate that rapidly activated atrial myocytes undergo structural remodelling, presenting as degradation of myosin and cardiac troponins, in an oxidative stress-dependent manner. Tachycardia up-regulated cardiac Nox isoforms and NADPH oxidasederived ROS production contributed to tachycardia-induced oxidative stress. Furthermore, tachycardia-stimulated TGF-b production is involved in tachycardia-induced oxidative stress and cellular structural remodelling in an autocrine/paracrine manner. There is a crosstalk between NADPH oxidases and Smad3 (a downstream mediator of TGF-b) in mediating tachycardia-induced oxidative stress. A schematic summary of these mechanisms is shown in Supplementary material online, Figure S5 . Finally, the up-regulation of TGF-b and oxidative stress coexisted with myosin degradation in atrial tissues of AF-patients.
AF and myofibril degradation
The involvement of myofibril degradation in the pathogenesis of AF has been the subject of intense investigation. Electrical pacing-induced AF in goat leads to substantial atrial structural changes, including loss of contractile elements, beginning in perinuclear areas and extending peripherally. 3 Clinical studies also demonstrate atrial myolysis in patients with chronic AF. 30, 31 In vitro, rapidly paced HL-1 myocytes display myocyte remodelling, including myolyis. 19, 20 Therefore, we utilized HL-1 cells to investigate molecular mechanisms underlying tachycardia-induced cellular structural remodelling. To our knowledge, this is the first study to clarify the intracellular signalling cascades involved in tachypacing-induced cellular structural remodelling.
Oxidative stress in AF
Numerous clinical and experimental studies have demonstrated the association of AF with oxidative stress, although most of them focus on atrial fibrosis. 6 -11 In this study, we have explored the previously poorly understood relationship between oxidative stress and Oxidative stress and TGF-b in AF remodelling atrial myofibril degradation. Potential inducers of oxidative stress in myocytes include the mitochondrial electron transport chains, xanthine oxidases, 'uncoupled' nitric oxide synthases, and NADPH oxidases. 26 Among these sources, NADPH oxidases are considered to be unique because they generate ROS in a highly regulated manner and can amplify oxidative stress signals from other sources. 6 -11,26 NADPH oxidase-derived oxidative stress may promote AF via altering the expression of ion channels and Ca
2+
handling proteins, increasing extracellular matrix deposition, and modulating intracellular signalling. 9, 11, 23, 26, 32, 33 Our findings suggest that ROS derived from NADPH oxidases, especially Nox2 and 4 subunits, contributes to tachypacing-induced myofibril degradation. The main NADPH oxidase subunits involved in atrial myofibril degradation are compatible with those related to hypertrophy of ventricular myocytes and differentiation of fibroblasts. 6, 26, 28, 34 It is possible that there are common signalling cascades in mediating oxidative stress-induced pathological changes either at the atrial or ventricular level.
TGF-b and structural remodelling in AF
This study suggested an essential role of TGF-b in mediating atrial structural remodelling. Prior investigations have found increased TGF-b1 levels in the blood and atria of AF patients. 33, 35, 36 Furthermore, transgenic mice over-expressing activated cardiac TGF-b1 develop AF as a result of atrial fibrosis. 37 Our study further specifies that the up-regulation of TGF-b1 is originated from atrial myocytes in either in vitro pacing model of HL-1 cells or in vivo AF tissue. The increased TGF-b1 expression is accompanied by activation of its downstream target, Smad3. Previous work emphasized the production of TGF-b from cardiac fibroblasts, 12 -16 whereas our study implicates significant production by myocytes in response to rapid activation. TGF-b is classically operated by synthesis and release into the extracellular space, subsequently binding to its corresponding receptor. 27 Our results provide potential mechanistic insights into the findings of a previous study, which indicated that tachypaced atrial myocytes release substances that profoundly alter cardiac fibroblast functions, inducing an activated myofibroblast phenotype and increasing collagen expression. 16 Because tachypacing promotes atrial myocytes to generate and release TGF-b1 and TGF-b1 neutralization prevents tachypacing-induced oxidative stress, TGF-b is likely to be an important mediator for the self-perpetuating behaviour of AF. The mechanism of TGF-b-mediated cellular structural remodelling has also been elucidated in our study. Oxidative stress, NADPH oxidases, and Smad signals mediate TGF-b-induced remodelling, although Smad3 inhibition does not block tachypacing-induced myofibril degradation. One possible explanation for the failure of Smad3 siRNA to prevent pacing-induced myofibril degradation is that Smad3 inhibition may stimulate a pathway (or pathways) other than Nox/ROS to induce myofibril degradation. The interaction between NADPH oxidase-derived oxidative stress and TGF-b-dependent Smad pathways is still controversial, varying with targets and experimental designs. 28, 29 Our tachypacing model identifies a crosstalk between NADPH oxidases and Smad3 signalling in the induction of oxidative stress, agreeing with a previous study on TGF-b-induced differentiation of cardiac fibroblasts. 28 
Tachycardia induces myofibril degradation
A recent study demonstrates that numerous factors contribute to atrial hypocontractility, including action potential shortening, I CaLreduction, disturbed Ca 2+ wave propagation, abnormal Ca 2+ handling, and altered myofibril function. 38 Several clinical and experimental studies indicate that myofibril loss or degradation is an important factor in promoting AF-related atrial hypocontractility. 3, 19, 20, 30, 31 Calpain-activation is also known to contribute to tachycardia-induced myofibril degradation and atrial hypocontractility. 19, 20 In this study, we find that inhibition of oxidative stress and TGF-b1 neutralization attenuate tachypacing-stimulated calpain activation and myofibril degradation. These findings agree with previous studies at the ventricular level showing that TGF-b and oxidative stress contribute to ventricular contractile dysfunction via alterations in Ca 2+ handling proteins. 12, 13, 26, 28 Oxidative stress and TGF-b may become interesting therapeutic targets to prevent AF-induced structural remodelling.
Limitations of the study
We studied the response of HL-1 myocytes after 24-h pacing, which has been validated as a model for atrial tachycardia-remodelling. 16 -20 However, the culture conditions do not entirely replicate the in vivo environment. We identified TGF-b and ROS species as mediators of autocrine/paracrine effects, but a role for other factor(s) cannot be excluded.
Potential significance
Our results demonstrate that atrial tachypacing induces oxidative stress and the up-regulation of TGF-b, which may contribute to the self-perpetuating behaviour of AF with respect to structural remodelling. As is known, structural remodelling induced by myofibril degradation may result in atrial hypocontractility (atrial stunning), which in turn may enhance the risk of systemic embolization even after successful cardioversion or radiofrequency catheter ablation of AF.
1,2
Intervention into AF-induced oxidative stress and TGF-b may be potentially effective in restoring atrial contractility after rhythm recovery. Further animal and clinical studies are needed to clarify this issue.
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Supplementary material is available at Cardiovascular Research online.
